1. Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses
- Author
-
Yufei Shi, Huda A BinEssa, Thamer S Alhussainan, Lamya Al-Ghofaili, Anwar M Al-Rabiah, Roua A. Al-Rijjal, Minjing Zou, Brian F. Meyer, Rajeev Pant, and Zayed S. Al-Zayed
- Subjects
0301 basic medicine ,Mutation rate ,Multiple osteochondroma ,Hereditary multiple exostoses ,DNA Mutational Analysis ,Population ,Saudi Arabia ,lcsh:Medicine ,Biology ,N-Acetylglucosaminyltransferases ,medicine.disease_cause ,03 medical and health sciences ,Exon ,0302 clinical medicine ,medicine ,Humans ,Pharmacology (medical) ,EXT12 ,Osteochondromas ,Multiplex ligation-dependent probe amplification ,Exostoses ,education ,Genetics (clinical) ,Genetics ,Mutation ,education.field_of_study ,Research ,lcsh:R ,Genetic disorder ,Exons ,General Medicine ,EXT1 ,medicine.disease ,030104 developmental biology ,030220 oncology & carcinogenesis ,Exostoses, Multiple Hereditary - Abstract
Background Hereditary Multiple Exostoses (HME), also known as Multiple Osteochondromas (MO) is a rare genetic disorder characterized by multiple benign cartilaginous bone tumors, which are caused by mutations in the genes for exostosin glycosyltransferase 1 (EXT1) and exostosin glycosyltransferase 2 (EXT2). The genetic defects have not been studied in the Saudi patients. Aim of study We investigated mutation spectrum of EXT1 and EXT2 in 22 patients from 17 unrelated families. Methods Genomic DNA was extracted from peripheral leucocytes. The coding regions and intron–exon boundaries of both EXT1 and EXT2 genes were screened for mutations by PCR-sequencing analysis. Gross deletions were analyzed by MLPA analysis. Results EXT1 mutations were detected in 6 families (35%) and 3 were novel mutations: c.739G > T (p. E247*), c.1319delG (p.R440Lfs*4), and c.1786delA (p.S596Afs*25). EXT2 mutations were detected in 7 families (41%) and 3 were novel mutations: c.541delG (p.D181Ifs*89), c.583delG (p.G195Vfs*75), and a gross deletion of approximately 10 kb including promoter and exon 1. Five patients from different families had no family history and carried de novo mutations (29%, 5/17). No EXT1 and EXT2 mutations were found in the remaining four families. In total, EXT1 and EXT2 mutations were found in 77% (13/17) of Saudi HME patients. Conclusion EXT1 and EXT2 mutations contribute significantly to the pathogenesis of HME in the Saudi population. In contrast to high mutation rate in EXT 1 (65%) and low mutation rate in EXT2 (25%) in other populations, the frequency of EXT2 mutations are much higher (41%) and comparable to that of EXT1 among Saudi patients. De novo mutations are also common and the six novel EXT1/EXT2 mutations further expands the mutation spectrum of HME.
- Published
- 2021
- Full Text
- View/download PDF